๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Management of cytomegalovirus infection after liver transplantation

โœ Scribed by Priya Sampathkumar; Carlos V. Paya

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
118 KB
Volume
6
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

โœฆ Synopsis

C ytomegalovirus (CMV) is a ubiquitous herpes virus that, together with human herpesvirus type 6 (HHV-6) and HHV-7, belongs to the ฮฒ-herpesvirus family. Like other herpes viruses, CMV establishes lifelong latent infections. Infection with CMV is common in all populations, but is infrequently associated with symptomatic illness in healthy hosts. However, CMV is a major cause of morbidity and mortality in transplant recipients. CMV infection is the single most common opportunistic infection after solidorgan transplantation and directly and indirectly affects the outcome after orthotopic liver transplantation (OLT).

๐Ÿ“œ SIMILAR VOLUMES

Cytomegalovirus infection after liver tr
Cytomegalovirus infection after liver transplantation
โœ Raymund R. Razonable ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 168 KB

## Key Points 1. Cytomegalovirus (CMV) is a common infection after liver transplantation and manifests as an asymptomatic infection or clinically as CMV syndrome (fever and myelosuppression) or tissue-invasive CMV disease. 2. The most common risk factor for CMV disease is donor positivity and recip

Is cytomegalovirus infection dangerous i
Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation?
โœ Jong Man Kim; Sung-Joo Kim; Jae-Won Joh; Choon Hyuck David Kwon; Sanghyun Song; ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 304 KB

Cytomegalovirus (CMV) infections contracted after liver transplantation put patients at an increased risk of morbidity and mortality. We analyzed the effects of CMV infection by time of onset, mortality, and graft failure risk factors in liver recipients who were CMV donor-positive/recipient-positiv

Delayed-onset primary cytomegalovirus di
Delayed-onset primary cytomegalovirus disease after liver transplantation
โœ Supha K. Arthurs; Albert J. Eid; Rachel A. Pedersen; Ross A. Dierkhising; Walter ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB ๐Ÿ‘ 1 views

Clinical practice guidelines recommend antiviral prophylaxis to cytomegalovirus (CMV) donor-positive/recipient-negative (D+/R-) liver transplant recipients. We assessed the outcome of this strategy by determining the incidence, clinical features, and risk factors of CMV disease among CMV D+/R- liver

Who among cytomegalovirus-seropositive l
Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
โœ Nina Singh; Cheryl Wannstedt; Lois Keyes; Marilyn M. Wagener; Thomas V. Cacciare ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB

A vast majority of the transplant recipients are cytomegalovirus (CMV)-seropositive (R+). We sought to assess variables predictive of CMV infection, specifically in R+ liver transplant recipients. Study patients comprised 182 consecutive liver transplant recipients who survived at least 14 days afte

Hepatitis G virus infection before and a
Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database
โœ Hoofnagle, J H ;Lombardero, M ;Wei, Y ;Everhart, J ;Wiesner, R ;Zetterman, R ;Yu ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 112 KB

The hepatitis G virus is a newly discovered flavivirus that has been linked to acute and chronic hepatitis of unknown cause. We determined the prevalence of hepatitis G virus infection in 179 selected patients undergoing liver transplantation at three centers participating in the National Institute